Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

10.04 +0.96 (+10.57%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Emergent BioSolutions (EBS) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

EBS earnings call for the period ending September 30, 2022.

Via The Motley Fool

Emergent BioSolutions Reports Financial Results For Third Quarter 2022

November 08, 2022

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines

November 01, 2022

From Emergent BioSolutions

Via GlobeNewswire

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

October 27, 2022

From SAB Biotherapeutics, Inc.

Via GlobeNewswire

FDA Issues Warning Letter For Emergent Bio's Manufacturing Facility ↗

August 15, 2022

Via Benzinga

Ranking the 7 Top Small-Cap Stocks to Buy From Best to Worst ↗

October 24, 2022

Although blue chips provide greater predictability, these top small-cap stocks to buy may drive intense growth for speculators.

Via InvestorPlace

Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Conference Call on November 8, 2022

October 18, 2022

From Emergent BioSolutions

Via GlobeNewswire

Emergent Shares Decline Following Commencement Of Initial-Stage Lassa Virus Vaccine Candidate Study ↗

September 06, 2022

Emergent BioSolutions (NYSE: EBS) has dosed first patient in its Phase 1 study evaluating the safety and immunogenicity of EBS-LASV in healthy subjects. EBS-LASV is a recombinant VSV-vectored Lassa...

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment ↗

July 08, 2022

Via Benzinga

3 Top Monkeypox Stocks to Buy Right Now ↗

August 24, 2022

With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.

Via InvestorPlace

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗

August 23, 2022

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.

Via Benzinga

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗

August 19, 2022

Via Benzinga

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗

August 18, 2022

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.

Via Benzinga

WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant ↗

August 18, 2022

Via Benzinga

A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring ↗

August 17, 2022

Blue Water Vaccines Inc (NASDAQ: BWV)

Via Benzinga

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗

August 17, 2022

Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide,

Via Benzinga

WeTrade's Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits? ↗

August 16, 2022

Via Benzinga

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus ↗

August 02, 2022

Via Benzinga

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗

August 02, 2022

FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.

Via Benzinga

Recap: Emergent BioSolutions Q2 Earnings ↗

August 01, 2022

Emergent BioSolutions (NYSE:EBS) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears ↗

August 01, 2022

Monkeypox stocks are rallying today amid worries about a shortage of vaccines for the illness in the United States.

Via InvestorPlace

Earnings Outlook For Emergent BioSolutions ↗

July 29, 2022

Emergent BioSolutions (NYSE:EBS) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Emergent...

Via Benzinga

Earnings Scheduled For August 1, 2022 ↗

August 01, 2022

Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.

Via Benzinga

Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency ↗

July 25, 2022

Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.

Via InvestorPlace

WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 25, 2022

Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...

Via Benzinga

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Emergent BioSolutions Inc. Common Stock (NY:EBS)

All News about Emergent BioSolutions Inc. Common Stock

Starting at $3.75/week.

Subscribe Today